Myers W O, Davis K, Foster E D, Maynard C, Kaiser G C
Ann Thorac Surg. 1985 Sep;40(3):245-60. doi: 10.1016/s0003-4975(10)60037-9.
The overall surgical survival data in the Coronary Artery Surgery Study (CASS) registry have not been published to date, pending the report of the randomized medical-surgical comparison (CASS randomized trial). Non-randomized surgical survival data from the CASS registry are given in this article. The overall medical survival data from the registry were reported previously as a natural history study. There were 8,991 patients in the registry portion of CASS who had primary isolated coronary artery bypass grafting and 8,971 with follow-up of more than 30 days. The 5-year survival for all 8,971 patients was 90%, and the operative mortality was 2.37%. Patients with left main coronary artery disease had an operative mortality of 3.84% and a 5-year survival of 85%, while patients with lesions in other vessels had an operative mortality of 2.12% and a 5-year survival of 91%. Among patients without left main coronary disease, the 5-year survival was 93% in those with single-vessel and 92% in those with double-vessel disease (operative mortality was 1.50% and 1.92%, respectively) and 88% in patients with triple-vessel disease (operative mortality was 2.62%; p = 0.009). When results for patients with left main coronary artery obstruction were compared with those for triple-vessel disease, the 5-year survival figures were 85% and 88%, respectively (p = 0.02) and the operative mortality, 3.84% and 2.62%, respectively (p = 0.03). Patients with normal or nearly normal left ventricular (LV) function (i.e., LV segmental wall motion scores ranging from 5 through 11) had a 5-year survival of 92% and an operative mortality of 1.97%. Patients with moderate impairment (LV score range, 12 through 16) had a 5-year survival of 80% and an operative mortality of 4.21%. In those with poor ventricular function (LV score of 17 or greater), the 5-year survival was 65% and the operative mortality was 6.21%. The difference in survival among the three groups was significant (p less than 0.0001). Of 29 variables used in a stepwise Cox regression analysis, LV wall motion score, congestive heart failure score, age, number of operable vessels, smoking history, LV end-diastolic pressure, and percent of left main coronary artery stenosis were found to have a significant effect on long-term survival (excluding 30-day mortality), and these variables plus surgical priority and height influenced surgical mortality. When height was used in the Cox proportional hazards model, female sex was no longer a significant variable.
冠状动脉外科研究(CASS)登记处的总体手术生存数据至今尚未公布,有待随机药物-手术对照研究(CASS随机试验)的报告。本文给出了CASS登记处的非随机手术生存数据。该登记处的总体药物生存数据先前已作为一项自然史研究报告。CASS登记部分有8991例患者接受了原发性单纯冠状动脉搭桥术,其中8971例有超过30天的随访。所有8971例患者的5年生存率为90%,手术死亡率为2.37%。左主干冠状动脉疾病患者的手术死亡率为3.84%,5年生存率为85%,而其他血管病变患者的手术死亡率为2.12%,5年生存率为91%。在无左主干冠状动脉疾病的患者中,单支血管病变患者的5年生存率为93%,双支血管病变患者为92%(手术死亡率分别为1.50%和1.92%),三支血管病变患者为88%(手术死亡率为2.62%;p = 0.009)。将左主干冠状动脉阻塞患者的结果与三支血管病变患者的结果进行比较时,5年生存率分别为85%和88%(p = 0.02),手术死亡率分别为3.84%和2.62%(p = 0.03)。左心室(LV)功能正常或接近正常的患者(即LV节段壁运动评分在5至11之间)5年生存率为92%,手术死亡率为1.97%。中度受损患者(LV评分范围为12至16)5年生存率为80%,手术死亡率为4.21%。心室功能差的患者(LV评分为17或更高)5年生存率为65%,手术死亡率为6.21%。三组之间的生存差异具有显著性(p < 0.0001)。在逐步Cox回归分析中使用的29个变量中,LV壁运动评分、充血性心力衰竭评分、年龄、可手术血管数量、吸烟史、LV舒张末期压力和左主干冠状动脉狭窄百分比被发现对长期生存(不包括30天死亡率)有显著影响,这些变量加上手术优先级和身高影响手术死亡率。当在Cox比例风险模型中使用身高时,女性性别不再是一个显著变量。